Mapping Global Prevalence of and Recent Vaccine Development to Tackle It.
Issue Date
2021-06-01Keywords
Acinetobacter baumanniiESKAPE
Antimicrobial resistance
immune response
Vaccines
virulence factors
Metadata
Show full item recordJournal
VaccinesDOI
10.3390/vaccines9060570PubMed ID
34205838Item Type
ArticleLanguage
enISSN
2076-393Xae974a485f413a2113503eed53cd6c53
10.3390/vaccines9060570
Scopus Count
Collections
The following license files are associated with this item:
- Creative Commons
Related articles
- Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
- Authors: Jain M, Sharma A, Sen MK, Rani V, Gaind R, Suri JC
- Issue date: 2019 Mar
- Understanding Pseudomonas aeruginosa-Host Interactions: The Ongoing Quest for an Efficacious Vaccine.
- Authors: Sainz-Mejías M, Jurado-Martín I, McClean S
- Issue date: 2020 Dec 5
- Multidrug resistant Acinetobacter baumannii isolates from a teaching hospital.
- Authors: Joshi SG, Litake GM, Niphadkar KB, Ghole VS
- Issue date: 2003 Jun
- Acinetobacter baumannii Isolated from Lebanese Patients: Phenotypes and Genotypes of Resistance, Clonality, and Determinants of Pathogenicity.
- Authors: Dahdouh E, Hajjar M, Suarez M, Daoud Z
- Issue date: 2016
- Promising Acinetobacter baumannii Vaccine Candidates and Drug Targets in Recent Years.
- Authors: Tan YC, Lahiri C
- Issue date: 2022